ABO-Incompatible Transfusions and Severe Allergic Reactions – ISBT
International Society of Blood Transfusion (ISBT) shared a post on LinkedIn about a recent article by Lucile Malard et al. published in Vox Sanguinis:
“Recently published in Vox Sanguinis
Association between group B major ABO-incompatible platelet or plasma transfusion and severe allergic reactions: A nationwide haemovigilance analysis suggesting a role for α-gal syndrome.
Key takeaways:
- Transfusing group B or AB platelets/plasma to group O recipients in France is linked to higher risk of severe allergic transfusion reactions (ATR).
- The risk is stronger with platelet transfusions than plasma, possibly related to α-gal syndrome.
- Recommendation: Group O recipients should receive ABO-identical platelets or plasma whenever possible.
A step forward in safer, personalized transfusion care.”
Title: Association between group B major ABO-incompatible platelet or plasma transfusion and severe allergic reactions: A nationwide haemovigilance analysis suggesting a role for α-gal syndrome. A Biomedical Excellence for Safer Transfusion Collaborative study
Authors: Lucile Malard, Cléo Beuscart, Luc de Chaisemartin, Virginie de La Taille, Catherine Humbrecht, Syria Laperche, Pierre Tiberghien
Read the Full Article on Vox Sanguinus Journal

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?